Pharsight

Drugs that contain Clonidine

1. Nexiclon Xr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8337890 ATHENA Modified release formulations containing drug-ion exchange resin complexes
Apr, 2027

(3 years from now)

US8623409 ATHENA Clonidine formulation
Sep, 2031

(7 years from now)

Market Authorisation Date: 03 December, 2009

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

NEXICLON XR family patents

Family Patents